Cargando…
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma is a non-curable disease and new therapeutic approaches are needed. PAPTP and PCARBTP, two novel mitochondria-specific inhibitors of the Kv1.3 ion channel, are effective in killing cultured myeloma cell lines and myeloma cells isolated from patient punctates, while h...
Autores principales: | Kadow, Stephanie, Schumacher, Fabian, Kramer, Melanie, Hessler, Gabriele, Scholtysik, René, Oubari, Sara, Johansson, Patricia, Hüttmann, Andreas, Reinhardt, Hans Christian, Kleuser, Burkhard, Zoratti, Mario, Mattarei, Andrea, Szabò, Ildiko, Gulbins, Erich, Carpinteiro, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032553/ https://www.ncbi.nlm.nih.gov/pubmed/35454865 http://dx.doi.org/10.3390/cancers14081955 |
Ejemplares similares
-
Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro
por: Naser, Eyad, et al.
Publicado: (2020) -
Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
por: Hashemi Arani, Fahimeh, et al.
Publicado: (2022) -
Acid Sphingomyelinase Deficiency Ameliorates Farber Disease
por: Beckmann, Nadine, et al.
Publicado: (2019) -
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells
por: Leanza, Luigi, et al.
Publicado: (2012) -
Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry
por: Wigger, Dominik, et al.
Publicado: (2019)